136 related articles for article (PubMed ID: 19081507)
21. Medical oncology in the 1990s.
Braverman AS
Lancet; 1991 Apr; 337(8746):901-2. PubMed ID: 1672980
[No Abstract] [Full Text] [Related]
22. Neuro-Oncology.
Batchelor T; Wick W
Semin Neurol; 2018 Feb; 38(1):3-4. PubMed ID: 29548045
[No Abstract] [Full Text] [Related]
23. Neurooncology--present and future.
Grisold W
Onkologie; 2004 Jun; 27(3):234-6. PubMed ID: 15264332
[No Abstract] [Full Text] [Related]
24. A radical rethinking of treatment. The aim is to make cancer curable or a manageable chronic disease.
Hobson K
US News World Rep; 2008 Nov 3-10; 145(10):48-50, 53. PubMed ID: 18998442
[No Abstract] [Full Text] [Related]
25. Advances in pediatric neuro-oncology.
Kieran MW
Curr Opin Neurol; 2000 Dec; 13(6):627-34. PubMed ID: 11148661
[TBL] [Abstract][Full Text] [Related]
26. The role of tumor board conferences in neuro-oncology: a nationwide provider survey.
Snyder J; Schultz L; Walbert T
J Neurooncol; 2017 May; 133(1):1-7. PubMed ID: 28421461
[TBL] [Abstract][Full Text] [Related]
27. New Agents in Clinical Oncology. 24 November 2006, London, UK.
Martin S
IDrugs; 2007 Feb; 10(2):99-101. PubMed ID: 17285459
[No Abstract] [Full Text] [Related]
28. Primary nervous system lymphoma.
Plotkin SR; Batchelor TT
Curr Treat Options Oncol; 2002 Dec; 3(6):525-35. PubMed ID: 12392641
[TBL] [Abstract][Full Text] [Related]
29. Pediatric oncology: past, present, and new modalities of treatment.
Bertolone K
J Intraven Nurs; 1997; 20(3):136-40. PubMed ID: 9214925
[TBL] [Abstract][Full Text] [Related]
30. [The current potentials and outlook for drug therapy in oncology].
Gershanovich ML; Borisov VI; Sidorenko IuS; Tiuliandin SA; Gorbunova VA
Vopr Onkol; 1995; 41(2):116-24. PubMed ID: 7483406
[No Abstract] [Full Text] [Related]
31. Neuro-oncology: a maturing discipline.
Obbens EA; Fields WS
Clin Neurol Neurosurg; 1984; 86(4):251-3. PubMed ID: 6096057
[No Abstract] [Full Text] [Related]
32. [Glioblastoma treatment in 2010].
Djedid R; Tomasi O; Haidara A; Rynkowski M; Lefranc F
Rev Med Brux; 2009; 30(5):496-505. PubMed ID: 19998795
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in medical oncology--1995-1996.
Sikov WM
Med Health R I; 1996 Mar; 79(3):92-9. PubMed ID: 8901289
[No Abstract] [Full Text] [Related]
34. [N. N. Petrov Research Institute of Oncology: present and future].
Beliaev AM
Vopr Onkol; 2012; 58(2):140-7. PubMed ID: 22774516
[No Abstract] [Full Text] [Related]
35. What's new in surgical oncology.
Norton JA
J Am Coll Surg; 1996 Feb; 182(2):122-9. PubMed ID: 8564043
[No Abstract] [Full Text] [Related]
36. Introduction. Update on adult neuro-oncology.
Colman H; Westphal M; Sampson JH
Neurosurg Focus; 2018 Jun; 44(6):E1. PubMed ID: 29852765
[No Abstract] [Full Text] [Related]
37. [Oncogenes in neuro-oncology].
Lalaiants IE
Zh Vopr Neirokhir Im N N Burdenko; 1990; (6):28-30. PubMed ID: 1705739
[No Abstract] [Full Text] [Related]
38. Introduction and commentary: paving the way for biosimilars in oncology, part 2: focus on safety and clinical trial considerations.
Abraham J
Semin Oncol; 2014 Feb; 41 Suppl 1():S1-2. PubMed ID: 24560023
[No Abstract] [Full Text] [Related]
39. Introduction and commentary: Paving the way for biosimilars in oncology.
Abraham J
Semin Oncol; 2013 Dec; 40 Suppl 1():S1-4. PubMed ID: 24267943
[No Abstract] [Full Text] [Related]
40. Advances in drug development: off-label drug utilization in oncology.
de Souza JA
Clin Adv Hematol Oncol; 2011 Jun; 9(6):473-5. PubMed ID: 21841748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
